These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 16026323)

  • 1. Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.
    Obrosova IG; Julius UA
    Curr Vasc Pharmacol; 2005 Jul; 3(3):267-83. PubMed ID: 16026323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
    Pacher P; Obrosova IG; Mabley JG; Szabó C
    Curr Med Chem; 2005; 12(3):267-75. PubMed ID: 15723618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.
    Kiss L; Szabó C
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():29-37. PubMed ID: 15962096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes.
    Xu B; Chiu J; Feng B; Chen S; Chakrabarti S
    Diabetes Metab Res Rev; 2008; 24(5):404-12. PubMed ID: 18351623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase / polyol inhibitors for diabetic retinopathy.
    Obrosova IG; Kador PF
    Curr Pharm Biotechnol; 2011 Mar; 12(3):373-85. PubMed ID: 20939801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) Polymerase-1: An Update on Its Role in Diabetic Retinopathy.
    Sun J; Chen L; Chen R; Lou Q; Wang H
    Discov Med; 2021; 32(165):13-22. PubMed ID: 35219352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients.
    Shen H; Zhao J; Liu Y; Sun G
    J Diabetes Res; 2018; 2018():3458615. PubMed ID: 30116739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the pathogenesis of diabetic neuropathy.
    Obrosova IG
    Curr Diab Rep; 2003 Dec; 3(6):439-45. PubMed ID: 14611738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
    Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
    Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.
    Obrosova IG; Drel VR; Pacher P; Ilnytska O; Wang ZQ; Stevens MJ; Yorek MA
    Diabetes; 2005 Dec; 54(12):3435-41. PubMed ID: 16306359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
    Drel VR; Xu W; Zhang J; Pavlov IA; Shevalye H; Slusher B; Obrosova IG
    Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction.
    Mabley JG; Soriano FG
    Curr Vasc Pharmacol; 2005 Jul; 3(3):247-52. PubMed ID: 16026321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation.
    Minchenko AG; Stevens MJ; White L; Abatan OI; Komjáti K; Pacher P; Szabó C; Obrosova IG
    FASEB J; 2003 Aug; 17(11):1514-6. PubMed ID: 12824290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion.
    Terashima T; Kojima H; Chan L
    FASEB J; 2012 Jan; 26(1):295-308. PubMed ID: 21978940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.
    Obrosova IG; Li F; Abatan OI; Forsell MA; Komjáti K; Pacher P; Szabó C; Stevens MJ
    Diabetes; 2004 Mar; 53(3):711-20. PubMed ID: 14988256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.
    Pacher P; Szabó C
    Antioxid Redox Signal; 2005; 7(11-12):1568-80. PubMed ID: 16356120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications.
    Szabó C
    Pharmacol Res; 2005 Jul; 52(1):60-71. PubMed ID: 15911334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications.
    Chiu J; Xu BY; Chen S; Feng B; Chakrabarti S
    Can J Physiol Pharmacol; 2008 Jun; 86(6):365-72. PubMed ID: 18516100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
    Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C
    Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.
    Szabó C; Biser A; Benko R; Böttinger E; Suszták K
    Diabetes; 2006 Nov; 55(11):3004-12. PubMed ID: 17065336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.